Category: juvenile
CMP INFANTO-JUVENILE BELLEY
010783009 010788248 CMP INFANTO-JUVENILE BELLEY CMP ENFANTS BELLEY SIREN : 775544562
View DetailsCMP INFANTO-JUVENILE GUIDANCE
010783009 010002236 CMP INFANTO-JUVENILE GUIDANCE CMP ENFANTS SAINTE-MADELEINE SIREN : 7
View DetailsProgramme d'éducation thérapeutique du patient autorisés - Maladies rares adolescent
Programme d'éducation thérapeutique du patient autorisés - Maladies rares adolescent Intitulé : E
View DetailsROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab)
ROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatment
View DetailsORENCIA 125 MG INJ SRG 1 ML + P/A (Abatacept)
ORENCIA 125 MG INJ SRG 1 ML + P/A (Abatacept) - Maladie rare sans désignation orpheline In combin
View DetailsORENCIA 250 MG PERF FL + SRG (Abatacept)
ORENCIA 250 MG PERF FL + SRG (Abatacept) - Maladie rare sans désignation orpheline In combination
View DetailsHUMIRA 40 MG INJ FL 0,8 ML + NEC (Adalimumab)
HUMIRA 40 MG INJ FL 0,8 ML + NEC (Adalimumab) - Maladie rare sans désignation orpheline *In combi
View DetailsHUMIRA 40 MG INJ SRG 0,8 ML + T (Adalimumab)
HUMIRA 40 MG INJ SRG 0,8 ML + T (Adalimumab) - Maladie rare sans désignation orpheline *In combin
View DetailsHUMIRA 40 MG INJ STYLO 0,8 ML + T (Adalimumab)
HUMIRA 40 MG INJ STYLO 0,8 ML + T (Adalimumab) - Maladie rare sans désignation orpheline *In comb
View Details